TLDR
- Morgan Stanley downgraded ARM from Overweight to Equal-Weight
- Price target cut to $150 from $185
- Analyst flagged near-term risks including end market softness and DRAM supply constraints
- Arm’s move into chip making raises channel conflict risk with its own licensees
- Other analysts including Mizuho, UBS, and Needham remain bullish with higher price targets
Arm Holdings stock fell 3.7% in premarket trading Tuesday after Morgan Stanley downgraded the chip IP firm, citing near-term headwinds despite long-term optimism around its push into chip making.
Arm Holdings plc American Depositary Shares, ARM
Analyst Lee Simpson moved ARM from Overweight to Equal-Weight and cut his price target to $150 from $185. The downgrade came shortly after Arm announced its new AGI-oriented CPU and revealed Meta and OpenAI as its first two customers.
Simpson acknowledged the strategic logic behind Arm’s move. He said the company’s new CPU, built specifically for agentic AI workloads, shows the CPU is far from obsolete. He also praised Arm’s talent acquisition and early design delivery.
But the analyst was quick to flag the risks. He said the commercial ramp will take time, and near-term enthusiasm needs to be tempered.
Demand Backdrop a Key Concern
A big part of the concern is around demand. Simpson said investor focus is likely to shift back to Arm’s in-line guidance against a tough demand environment.
End market softness, combined with DRAM supply constraints, could slow growth in fiscal year 2027, he said. That’s a meaningful near-term risk for a stock that has carried a premium valuation.
Margin pressure is another factor. R&D and engineering costs are running high ahead of any meaningful chip revenue coming in, Morgan Stanley noted.
Channel Conflict Risk
One of the more pointed concerns in the note was around channel conflict. By moving into silicon, Arm is now competing — directly or indirectly — with some of the same companies it licenses its technology to.
Simpson said this raises the possibility of customer pushback, and argued investors shouldn’t dismiss that risk.
It’s a delicate position. Arm built its business on being a neutral supplier of chip architecture. Going deeper into the stack changes that dynamic.
Not everyone on Wall Street shares Morgan Stanley’s caution. Mizuho has a price target of $230 on ARM, citing AI data center upside. UBS sits at $175 with a Buy rating. Needham upgraded to Buy with a $200 target. Barclays also rates it Overweight with a $200 target.
ARM stock was trading at $148.77 at the time of the downgrade, with a market cap of around $158 billion. InvestingPro data flagged the stock as overvalued relative to its Fair Value estimate.
Considering a new stock? You may want to see what’s on our watchlist first.
Our team at Knockout Stocks follows top-performing analysts and market-moving trends to spot potential winners early. We’ve identified five stocks gaining quiet attention that could be worth watching now. Create your free account to unlock the full report and get ongoing stock insights.Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
